Ensign Peak Advisors, Inc
Position in UTHR — UNITED THERAPEUTICS Corp
CIK 1454984
SALT LAKE CITY, UT
Position in UTHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,331,403
-$666,247 QoQ
Shares Held
26,450
+4.6% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#149
of 874 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $86,377,339 across 19 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (16.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
175,946 | $29,653,938 | |
| 2 | ALKS |
Alkermes plc.
|
335,208 | $17,564,899 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
26,450 | $14,331,403 | |
| 4 | ZTS |
Zoetis Inc.
|
126,706 | $9,105,093 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
305,441 | $5,485,720 | |
| 6 | BIOA |
BioAge Labs, Inc.
|
141,698 | $3,473,017 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
95,081 | $2,339,943 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
40,850 | $1,383,998 |
All Filings in UTHR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,331,403 | 26,450 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $14,997,650 | 25,292 | Shares | Sole | 2026-08-18 | |
| 2025-12-31 | $13,075,353 | 26,835 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $13,951,728 | 33,281 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $9,889,150 | 34,415 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $11,527,448 | 37,394 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $13,286,895 | 37,657 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,265,041 | 37,017 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,727,808 | 33,677 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,081,147 | 26,472 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $7,144,226 | 32,490 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,617,691 | 33,726 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,905,057 | 35,810 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,604,617 | 20,560 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,461,119 | 16,042 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $15,924,814 | 76,057 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,185,112 | 64,442 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $11,694,302 | 65,182 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $12,642,192 | 58,507 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $13,393,124 | 72,560 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,490,578 | 47,325 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $8,278,192 | 49,490 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $7,313,393 | 48,181 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $31,315,454 | 310,054 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $17,158,405 | 141,805 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $4,294,281 | 45,284 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||